bio-relevant dissolution media
TRANSCRIPT
BIO-RELEVANT DISSOLUTION MEDIA
INTRODUCTION
Simulation of gastrointestinal conditions is essential to
adequately predict the in vivo behavior of poorlysoluble drugs. Simulating small intestinal conditionswith biorelevant media such as fasted state
simulatedintestinal fluid (FaSSIF) and fed state simulated
intestinalfluid (FeSSIF) has become standard practice in
manydissolution laboratories .
However, due to their complex composition, these media are expensive and, to date, need to be prepared on the day of the experiment.
The aim of the present study was to develop media that
are easier to prepare and are stable over a longer period, but can still serve the purpose of forecasting in vivo performance.
Criteria for developing simplified test media also include cost-effectiveness and the ability to adequately reflect the physicochemical properties of the bio relevant media FaSSIF or FeSSIF .
The aim of the present study was to develop media that
are easier to prepare and are stable over a longer period, but can still serve the purpose of forecasting in vivo performance.
Criteria for developing simplified test media also
include cost-effectiveness and the ability to adequately reflect the physicochemical properties of the bio relevant media FaSSIF or FeSSIF
PREPARATION OF BIORELEVANT MEDIA
MATERIALS Brij® 35 (polyoxyethyleneglycol dodecyl ether) Span® 80 (sorbitan monooleate) Tween® 20 (polyoxyethylene sorbitan
monolaurate) Tween® 40 (polyoxyethylene sorbitan monopalmitate)
Tween® 60 (polyoxyethylene sorbitan monostearate)
Tween® 80 (polyoxyethylene sorbitan monooleate)
PREPARATION OF BLANK FaSSIF
Dissolve 1.74 g of NaOH (pellets), 19.77 g of NaH2PO4.H2O or 17.19 g of anhydrous NaH2PO4, and 30.93g of NaCl in
5 L of purified water. Adjust the pH to exactly 6.5 using 1 N NaOH or 1 N HCl.
PREPARATION OF FaSSIF
Dissolve 3.3 g of sodium taurocholate in 500 mL blank
FaSSIF. Add 11.8 mL of a solution containing 100 mg /ml
lecithin in methylene chloride, forming an emulsion. The methylene chloride is eliminated under vacuum
at about 40°C. Draw a vacuum for fifteen minutes at 250 mbar, followed by 15 minutes at 100 mbar.
This results in a clear,micellar solution, having no perceptible odor of methylene chloride.
After cooling to room temperature, adjust the volume to
2 L with blank FaSSIF. For dissolution tests a volume of 500 mL is
recommended.
PREPARATION OF BLANK FeSSIF
Dissolve 20.2 g of NaOH (pellets), 43.25 g of glacial acetic acid, and 59.37 g of NaCl in 5 L of purified
water Adjust the pH to exactly 5.0 using 1 N NaOH or 1 N HCl.
PREPARATION OF FeSSIF
Dissolve 16.5 g of sodium taurocholate in 500 mL of blank FeSSIF. Add 59.08 mL of a solution containing 100mg/mL lecithin in methylene chloride, forming an
emulsion. The methylene chloride is eliminated under
vacuum at about 40°C. Draw a vacuum for fifteen minutes at
250 mbar, followed by 15 minutes at 100 mbar. This results in a clear to slightly hazy,micellar
solution having no perceptible odor of methylene chloride.
After cooling to room temperature, adjust the volume to 2 L with blank FeSSIF.
The recommended volume for simulating conditions in
the upper small intestine after a meal is one liter.
PHYSICAL CHEMICAL EVALUATION OF THE MEDIA
The pH of all test media was measured with a pH meter. The buffer capacity was quantified by potentiometric titration with 0.1 N hydrochloric acid. The osmolality was measured by semi-micro osmometry
(osmometer type Surface tension was determined with a bubble-pressure tensiometer
PHYSICO CHEMICAL PARAMETERS OF THE TEST MEDIA: TARGET VALUES AND TOLERANCES
SIMULATED FeSSIF SIMULATED FaSSIF
Parameter target value range of tolerance target value range of tolerance pH 6.5 ± 0.1 5.0 ± 0.1
Osmolality [mOsmol/kg] 270 ± 15 670 ± 15 Buffer capacity [mEq/pH/L] 12 ± 2 72 ± 2 Surface tension [mN/m] 54 ± 2 48 ± 2
BIO-RELEVANT MEDIUM
HCl (mL) 1.4 mL (conc. 12N HCl)
NaCl (g) 2.0 g (34.2 mM)
Deionized water 1 L
Na Taurocholate 1.61 g (3 mM)
Lecithin 0.56 g (0.75 mM)
KH2PO4 3.9 g
KCl 7.7 g
NaOH qs pH 6.5
Deionized water 1 L
Fasted Simulated Small Intestinal Fluid (FaSSIF)1
Simulated Gastric Fluid (SGF)
MEDIA PREPARATION
The biorelevant media FaSSIF and FeSSIF were prepared on the day of the experiment. FaSSIF was prepared as follows:
3.3 g sodium taurocholate was dissolved in approximately 500 mL of the blank FaSSIF.
The weight of this mixture was checked and noted (“weight 1”).
Then 11.8 mL of a methylene chloride solution containing 100 mg/mL lecithin (= 1.18 g lecithin, “weight 2”) was added.
This produced an emulsion (i.e., the resulting product was turbid).
The methylene chloride was then evaporated under vacuum using a Rotavap at a temperature of about 40 °C. About 10 min at 500 mbar followed by 30 min at about 50 mbar led to complete removal of the methylene chloride.
The result was a clear, micellar solution having no perceptible odor of methylene chloride. After cooling to room temperature, the weight of the solution was checked again.
The water lost to evaporation was replaced with demineralized water to obtain a total weight corresponding to the sum of “weight 1” and “weight 2.”
Finally, the volume was brought to 2 L with blank FaSSIF.
Likewise, FeSSIF was prepared by first dissolving 16.5 g sodium taurocholate in 500 mL of blank FeSSIF, checking and noting the weight (“weight 1”).
Subsequently, 59.1 Ml of a methylene chloride solution containing 100 mg/mL lecithin (= 5.91 g lecithin, “weight 2”) was added, resulting in an emulsion.
The methylene chloride was then evaporated under the conditions described for FaSSIF until a clear, micellar solution with no perceptible odor of methylene chloride was obtained.
After cooling to room temperature, the weight of the solution was checked again, and the water lost to evaporation was replaced with demineralized water to obtain a total weight corresponding to the sum of “weight 1” and “weight 2.”
Finally, the volume was brought to 2 L with blank FeSSIF.
These methods of manufacturing FaSSIF and FeSSIF
differed slightly from those proposed in the literature (11,12)
Simplified media containing different types and amount
of surfactants were prepared using blank FaSSIF and FeSSIF (i.e., the relevant buffers without sodium taurocholate and lecithin) as the basis. After the surfactant(s) were added, the media were
placed in the ultrasonic bath for 15 min and then stirred for another 15 min on a magnetic stirrer.
Subsequently, various physicochemical parameters such as pH, surface tension, critical micelle concentration, osmolality, and buffer capacity were measured and compared with those of the biorelevant media.
Challenges in early phase formulation development Dissolution in Bio-relevant media Simulated Gastric Fluid (SGF) and Fasted Simulated
Small Intestinal Fluid (FaSSIF) Medium Simple two-stage dissolution model (SGF followed by
FaSSIF)for weak acids and weak bases Five Merck case studies of using dissolution in bio-
relevant medium to guide formulation selection Conclusions Dissolution in bio-relevant medium can be a useful
tool for early formulation selection IVIVR established can be leveraged for future
formulation development and QC method development
ROLE OF BIORELEVANT MEDIA IN FORMULATION DEVELOPMENT
CHALLENGES IN EARLY PHASE FORMULATION DEVELOPMENT
Majority of the drug candidates have poor aqueous solubility
Early phase formulation needs to maximize bioavailability to ensure that API is delivered to the intended target
Variety of formulations options available Limited API and limited formulation materials In-vitro dissolution, if reflecting in-vivo performance,
can be used to guide formulation development
DESIRED DISSOLUTION FOR EARLY PHASE
Traditional Dissolution Desired Dissolution forVolume 500mL to 900mL Smaller volume
medium Aqueous or surfactant Bio-relevant medium: SGF, FaSSIF,
medium with 3-10X sink FeSSIF
Profile Complete release in 60min Relative release rate, ranking order
Detection HPLC or UV (online, offline) Real time measurement Focus on Bio-relevant Method and optimize formulation bioavailability Focus on performance checking (QC) method Bio-relevant media are designed to simulate gastrointestinal
conditions, and provide a higher probability of success in establishing in-
vitro and in-vivo relationships
CASE 1: FORMULATION DEVELOPMENT FOR A LOW SOLUBLE NEUTRAL COMPOUND
Compound A is a neutral compound. Aqueous solubility is < 0.01mg/mL in both SGF and FaSSIF
BCS II with high permeability Various formulations were developed for Phase I
LFC 1-3 with various lipid-surfactant vehicles Two Solid dosage forms with different type of
surfactants Bench-mark of safety assessment formulation Formulations are evaluated in bio-relevant medium (FaSSIF)
CASE 2: BIO-RELEVANT DISSSOLUTION IS MORE DISCRIMINATING
Formulation AUC0-24hr(μM*hr)
Cmax(μM)
Formulation-1 82.1 10.9
Formulation-3 69.1 10.3
Formulation 1 and 2 (filler type 1)have faster release thanformulation-3(filler type 2)in FaSSIF medium
Formulation-1 has slightly Higher bioavailability than formuation-3,correlate with in-vitro results in biorelevantmedium
In-vivo Animal PK result
CASE STUDY 3: FORMULATION SELECTION WITH 2-STAGE BIO RELEVANT DISSOLUTION
Dissolution was conducted in
90mL SGF and 180mL of FaSSIF
with USP II paddle (100rpm) The safety formulation
(10%tween) remain supersaturated
inSGF and Tween Solid formulation A has thehighest release in SGF and
FaSSIF In-vivo animal study showed
that solid formulation A has slightly lower, but comparable exposure to safety formulation
CASE STUDY 5: FORMULATION SELECTION IN FaSSIF MEDIUM
Dissolution was conducted in 500mL of FaSSIF medium
withUSP II paddle (100rpm) Formulation A and B release much faster than formulation
C In-vivo animal study confirm
the same ranking order observed invitro
Surfactant A was selected over
surfactant C
A SIMPLE DISSOLUTION MODELSGF OR FaSSIF
Target Concentration= projected efficacious dose/volume of bio-relevant medium
INVIVO
BIO -RELEVANT MEDIUM VOLUME ADJUSTED BASED ON FORMULATION AVAILABILITY AND TARGET CONCENTRATION
Micro Dissolution USP II Paddle
4-20 mL
200mL 1L
Vessel Type Volume Agitation
Micro Dissolution 4-20mL Stir bar
Vankel 200mL 50-200mL Paddle
Vankel 1000mL 250-1000mL Paddle
CONCLUSION
Selected media containing synthetic surfactants with
physicochemical properties similar to those of FaSSIF and FeSSIF were identified.
These can be used to replace biorelevant test media for screening formulations if it can be shown that solubility and dissolution of the drug in these simplified media are similar to the profiles in biorelevant media prepared with bile components.
BIBILOGRAPHY
1. Dressman, J. B., Reppas, C. – In vitro-in vivo correlations for lipophilic, poorly water-soluble drugs. B.T.Gattefosse, 93: 91–100, 2000.
2. Nicolaides, E., Symillides,M., Dressman, J. B., Reppas, C.– Biorelevant dissolution testing to predict the plasma of lipophilic drugs after oral administration. Pharm. Res., 18(3): 380–388, 2001.
3. Horter,D.,Dressman, J. B. – Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract. Adv. Drug Del. Rev., 46: 75–87, 2001.
4. Lobenberg, R., Kramer, J., Shah,V. P., Amidon, G. L.,Dressman, J. B. – Dissolution testing as a prognostic tool for oral drug absorption: Dissolution behavior of glibenclamide. Pharm. Res., 17: 439–444, 2000.